Article
Clinical Severity May Not Correlate With Psychological Burden of Psoriasis, Study Finds
Psoriasis as an Inflammatory Disease, and What’s Changed Over Time
Icotrokinra Shows Clear Skin in 75% of Adolescents With Plaque Psoriasis in Phase 3 Trial
Women Have Lower Drug Survival With Biologics for Psoriasis, Including IL-17 and IL-23 Inhibitors
Tildrakizumab Effective Up to Nearly 3 Years Regardless of BSA Affected, Obesity
Bimekizumab Reduces Inflammation, Cardiovascular Risk